Healthcare -
Biotechnology - NASDAQ - US
$ 2.47
3.78 %
$ 119 M
Market Cap
-1.79
P/E
SAVA - COST OF REVENUE
Cost of Revenue SAVA - Cassava Sciences, Inc.
89.4 M
LAST VALUE
1194.06%
2 YEAR CAGR
319.30%
5 YEAR CAGR
166.67%
10 YEAR CAGR